Is a complete ZURA research report available?

No complete published report is available for Zura Bio Limited (ZURA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Zura Bio Limited (ZURA)

NASDAQ: ZURA · USD

$5.23

-0.06 (-1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ZURA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	496.8M
Net income (ttm)	-106.1M
EPS (ttm)	-$1.07
Shares out	95M
Volume	366,090
Beta	-0.03
Price target	$15.7	+199.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -106.1M
EPS (ttm): -$1.07
Market cap: 496.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ZURA indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001855644
Company name	Zura Bio Limited
Country	United States
Country code	US
Cusip	G9TY5A101
Employees	40
Employees Change	10%
Employees Change Percent	33.33
Enterprise value	$271.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	KYG9TY5A1016
Last refreshed	2026-07-25
Market cap	$496.8M
Market cap category	Small-Cap
Price	$5.23
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2836
Symbol	ZURA
Website	https://zurabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-21.36%
FCF yield	-14.64%
P/B ratio	2.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-106.1M
Net Income Growth Years	0%
Profit Per Employee	$-2.7M
ROA	-25.39
ROCE	-25.82
ROE	-40.96
ROIC	-27.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	209.71%
Cagr3y	-8.51%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$228.6M
Cash	$225.6M
Current Assets	$227M
Current Liabilities	$11.7M
Debt	$0
Equity	$216.9M
Liabilities	$11.7M
Long Term Assets	$1.6M
Long Term Liabilities	$0
Net Cash	$225.6M
Net Cash By Market Cap	$45.41
Net Cash Growth	32.26%
Net Debt Equity	$-1.04
Tangible Book Value	$216.9M
Tangible Book Value Per Share	$2.28
WACC	4.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	19.33
Net Working Capital	$-10.3M
Quick ratio	19.21
Working Capital	$215.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.31%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	209.47%
200-day SMA	4.95
3Y total return	-23.43%
50-day SMA	4.57
50-day SMA vs 200-day SMA	50under200
All Time High	37.55
All Time High Change	-86.07%
All Time High Date	2023-03-24
All Time Low	0.97
All Time Low Change	439.18%
All Time Low Date	2025-04-04
ATR	0.4
Beta	-0.03
Beta1y	-0.49
Beta2y	1.1
Ch YTD	-0.19
High	5.48
High52	7.44
High52 Date	2026-03-10
High52ch	-29.7%
Low	5.12
Low52	1.35
Low52 Date	2025-08-01
Low52ch	288.85%
Ma50ch	14.52%
Premarket Change Percent	3.03
Premarket Price	$5.45
Premarket Volume	570
Price vs 200-day SMA	5.61%
RSI	52.99
RSI Monthly	53.41
RSI Weekly	53.19
Sharpe ratio	1.57x
Sortino ratio	3
Total Return	-14.31%
Tr YTD	-0.19
Tr1m	21.49%
Tr1w	-4.04%
Tr3m	-5.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	5
Analyst Price Target Top	$18
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.12
Operating Income	$-81.5M
Price target	$15.67
Price Target Change	$200
Price Target Change Top	$244

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,745,411%
Float Percent	53.42%
Shares Insiders	11.13%
Shares Institutions	54.28%
Shares Out	94,997,710
Shares Qo Q	18.36%
Shares Yo Y	14.31%
Short Float	18.21%
Short Ratio	5.51
Short Shares	9.73

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-86.4M
Average Volume	1,481,635x
Bv Per Share	2.28
CAPEX	$-77,000
Ch1m	21.49
Ch1w	-4.04
Ch1y	209.5
Ch3m	-5.25
Ch3y	-23.43
Ch6m	-17.77
Change	-1.13%
Change From Open	-1.32
Close	5.29
Days Gap	0.19
Depreciation Amortization	56,000
Dollar Volume	1,914,650.7
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-56M
EBITDA	$-55.9M
EPS	$-1.07
F Score	2
FCF	$-72.8M
FCF EV Yield	-26.82x
FCF Per Share	$-0.77
Financing CF	127,777,000
Fiscal Year End	December
Founded	2,022
Investing CF	-77,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-19
Ma150	5.34
Ma150ch	-1.97%
Ma20	5.34
Ma20ch	-2.02%
Net CF	55,025,000
Next Earnings Date	2026-08-13
Open	5.3
Optionable	Yes
Position In Range	30.56
Ppne	125,000
Pre Close	5.29
Price Date	2026-07-24
Ptbv Ratio	2.29
Relative Volume	0.25x
Share Based Comp	13,696,000
Tr6m	-17.77%
Us State	Nevada
Volume	366,090

Zura Bio Limited (ZURA)

Coverage state: Market snapshot only — no published research

Generate the first ZURA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ZURA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ZURA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ZURA

Frequently asked questions